|Day Low/High||2.48 / 2.62|
|52 Wk Low/High||2.21 / 8.77|
The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.
It was the seventh best performer in the index during the first half of the year.
The chess game continues.
Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.
BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
One Wall Street firm thinks it's a real possibility.
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
Oxford sleep researcher Russell Foster argues that smartphone addiction is compromising the sleep time an average teenager is getting.
Analysts at Berenberg say traditional automakers remain complacent about electric vehicles.
Uber thanked the dedication of the drivers making those trips possible and awarded each $500.
The firm expects the company to lower its labor costs and increase sales.
Drones to the rescue!
CVS wants to dictate health.
Staples Inc.'s sale to private equity firm Sycamore Partners LLC could open up deal doors for Office Depot Inc., including a potential takeover by Amazon.
It was the White House's energy week and the Senate was supposed to vote on healthcare, so obviously we were going to spend Friday talking about the National Enquirer.
We held back on any big portfolio moves as the quarter ended with bank stress test results and merger news.
Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and "waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands of Oklahomans."
Not that anyone would want 31 Teslas.
This is unlike anything I have ever seen before.
The FTC will likely accept a deal.
Shares of Paratek Pharmaceuticals, Opko Health and Endo International were among the biotech stock movers in premarket trading on June 30.
The St. Louis Fed President said the U.S. has 'certainly' worked without global central banks before.
Insiders say the Chinese-language speaker could come out as soon as next week.
It's the more affordably priced alternative to Google Home.